In this study, PSMA was investigated as a suitable target for urinary EVs (uEVs) derived from communicating prostate(-cancer) cells in order to provide the ability to specifically isolate them from urine samples in a possible clinical setting. The gene discussed is FOLH1; the disease is cancer.